21168 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA Bacterial cells; Fungal cells; Protozoal cells
Sub-classes:TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES
#2COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#3Innate Targeting of Adoptive Cellular Therapies
#4METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE SYSTEM FUNCTION
#5COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#6PHARMACEUTICAL COMPOSITION COMPRISING SUTTERELLA WADSWORTHENSIS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF COLON CANCER
#7INFECTIOUS PLASMODIUM SPOROZOITES GROWN IN VITRO
#8SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS
#9LIVE MYCOPLASMA SYNOVIAE VACCINE
#10METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#11COMPOSITIONS AND METHODS FOR ENHANCING EFFICACY AND REDUCING ADVERSE EFFECTS FROM COVID VACCINATION
#12SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#13A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#14SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#15COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#16Composition for inducing proliferation or accumulation of regulatory T cells
#17Infectious plasmodium sporozoites grown in vitro
#18TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA
#19CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS
#20POULTRY DRINKING WATER-BASED VACCINE DELIVERY SYSTEM AND METHOD
#21METHOD OF GENERATING VACCINES
#22UNIVERSAL MAMMALIAN INFLUENZA VACCINE
#23Bacterium capable of inducing TH1 cells
#24MICROENCAPSULATED ORAL STERNE VACCINE
#25Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
#26GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#27CONSTRUCTION METHOD OF RECOMBINANT DRUG-RESISTANT MYCOBACTERIUM BOVIS BACILLUS CALMETTE-GUERIN (BCG) STRAIN AND PHARMACEUTICAL COMPOSITION FOR TREATING TUBERCULOSIS (TB)
#28CLOSTRIDIOIDES DIFFICILE TCDB VARIANTS, VACCINES AND METHODS OF USE
#29Circumsporozoite proteins with increased expression in mammalian cells
#30Infectious sporozoites grown in vitro
#31ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#32Compositions and methods for regulation of chronic toxoplasma infection
#33Stabilisation of live mollicutes bacteria in a liquid composition
#34COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#35Compositions and methods for induction of Th17 cells
#36COMPOSITIONS COMPRISING BACTERIAL STRAINS
#37SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#38Targeted vaccination in the liver
#39Gel delivery system for treating poultry
#40BI-SPECIFIC ANTIBODIES AND USES THEREOF
#41System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
#42Immunomodulatory minicells and methods of use
#43Innate Targeting of Adoptive Cellular Therapies
#44Oral dissolving films containing microencapsulated vaccines and methods of making same
#45Nanovesicles derived from enhydrobacter bacteria, and use thereof
#46Yeast-based immunotherapy and type I interferon sensitivity
#47Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal species
#48Compositions comprising bacterial strains
#49Compositions and methods for the induction of CD8+ T-cells
#50Composition for inducing proliferation or accumulation of regulatory T cells
#51Rabbit coccidiosis vaccine and application thereof
#52Infectious plasmodium sporozoites grown in vitro
#53Mesothelin vaccines and model systems
#54Subunit vaccine delivery platform for robust humoral and cellular immune responses
#55Compositions and methods for the induction of CD8+ T-cells
#56Compositions comprising bacterial strains
#57COMPOSITIONS COMPRISING BACTERIAL STRAINS
#58Compositions and methods for the induction of CD8+ T-cells
#59METHODS OF PRIMING A SUS' IMMUNE SYSTEM
#60Antibody fragments for the treatment of biofilm-related disorders
#61Universal mammalian influenza vaccine
#62Fungal vaccine compositions and methods of use thereof
#63Glycolipid compositions and methods of use
#64Composition for inducing proliferation or accumulation of regulatory T cells
#65Composition for inducing proliferation or accumulation of regulatory T cells
#66COMPOSITIONS COMPRISING BACTERIAL STRAINS
#67Immunomodulatory minicells and methods of use
#68METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#69Method and apparatus for microneedle transdermal delivery
#70ACTINOBACILLUS PLEUROPNEUMONIAE RECOMBINANT TOXIN PROTEIN AND APPLICATION THEREOF
#71Gel for treating infectious bronchitis
#72Composition for inducing proliferation or accumulation of regulatory T cells
#73VLP-based vaccines for targeting secreted virulence factors
#74Means and methods for treating HBV
#75Composition for inducing proliferation or accumulation of regulatory T cells
#76Bi-specific antibodies and uses thereof
#77Vaccine strains of brachyspira hyodysenteriae
#78Compositions comprising bacterial strains
#79Compositions comprising bacterial strains
#80Oral dissolving films
#81Synthetic N-acetyl-muramic acid derivatives and uses thereof
#82PEPTIDES AND BINDING PARTNERS THEREFOR
#83Compositions and methods for treatment and prevention of uropathogenic infection
#84Soft gel delivery method for treating poultry
#85Infectious plasmodium sporozoites grown in vitro
#86Composition for inducing proliferation or accumulation of regulatory T cells
#87Interferon-β production modulating strains and methods for using same
#88Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
#89Vaccine compositions against pathogenic fungi and methods for use thereof
#90Vaccine formulation, preparation method therefor and use thereof
#91Subunit vaccine delivery platform for robust humoral and cellular immune responses
#92SYSTEM AND METHOD FOR DELIVERING GENETIC MATERIAL OR PROTEIN TO CELLS
#93Pertussis vaccines and methods of making and using
#94Compositions comprising bacterial strains
#95Tannin and anti-gliadin antibody compositions for treatment of a disease of the intestinal tract
#96Composition for inducing proliferation or accumulation of regulatory T cells
#97ENHANCED IMMUNE RESPONSE IN CATTLE UPON TREATMENT WITH NITRIC OXIDE
#98Immunomodulatory minicells and methods of use
#99Compositions comprising bacterial strains
#100Compositions comprising bacterial strains
#101Composition for inducing proliferation or accumulation of regulatory T cells
#102Method for producing outer membrane vesicles
#103Biomarker directed multi-target immunotherapy
#104Soft gel delivery system for treating poultry
#105Induction of mucosal tolerance to antigens
#106Composition for inducing proliferation or accumulation of regulatory T cells
#107Mesothelin vaccines and model systems
#108Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#109Nanospheres encapsulating bioactive material and method for formulation of nanospheres
#110Yeast-based immunotherapy and type I interferon sensitivity
#111Compositions and methods for induction of TH17 cells
#112Composition for inducing proliferation or accumulation of regulatory T cells
#113Bacterial compositions and methods of use thereof for treatment of immune system disorders
#114Interferon-β production modulating strains and methods for using same
#115Method of inducing tolerance to an allergen
#116Vaccine
#117Mucosal vaccine composition
#118Mesothelin Vaccines and Model Systems
#119Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#120Recombinant as a vaccine
#121Immunomodulatory minicells and methods of use
#122Adjuvant compositions and related methods
#123OMV vaccines
#124Peptides and binding partners therefor
#125Formulations
#126Campylobacter vaccine
#127Modified listeria bacteria and uses thereof
#128Bifidobacterium for dust mite allergy
#129COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#130Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition
#131Vaccine formulations comprising saponin-containing adjuvants
#132Bacterial biofilm matrix as a platform for protein delivery
#133Rodent parasites as platforms for a whole-organism malaria vaccine
#134Subunit vaccine delivery platform for robust humoral and cellular immune responses
#135Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#136Method of treating celiac disease
#137Induction of mucosal tolerance to antigens
#138Induction of mucosal tolerance to antigens
#139Yeast-Based Vaccines as Immunotherapy
#140LIQUID VACCINE PREPARATIONS
#141Methods of Promoting Immune Tolerance
#142Formulations
#143Mucosal adjuvant composition
#144Interferon-β production modulating strains and methods for using same
#145YEAST-BASED VACCINES AS IMMUNOTHERAPY
#146vaccine
#147YEAST-HIV ANTIGEN COMPOSITIONS AND METHODS OF USING THE SAME
#148Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#149COMPOSITIONS AND METHODS FOR CONTROLLING DISEASES IN ANIMALS
#150INTACT MINICELLS AS VECTORS FOR DNA TRANSFER AND GENE THERAPY INVITRO AND INVIVO
#151VACCINATION FOR LAWSONIA INTRACELLULARIS
#152Strains of and uses thereof
#153Method of producing rough strains of bacteria and uses thereof
#154Mesothelin vaccines and model systems
#155Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
#156Helicobacter system and uses thereof
#157Soft gel delivery system for treating poultry
#158PATHOGEN FOR BACTERIAL POULTRY DISEASE
#159Yeast-based vaccines as immunotherapy
#160Vaccine formulations comprising saponin-containing adjuvants
#161Heterologous protection against provided by fur cells and the outer-membrane protein extracts thereof
#162Method of inducing tolerance to an allergen
#163for dust mite allergy
#164Plasmodium falciparum antigens and their vaccine and diagnostic applications
#165Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#166Interferon-β production modulating strains and methods for using same
#167Method of inducing immune tolerance to type I diabetes
#168Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#169Compositions and methods for controlling diseases in animals
#170BIFIDOBACTERIUM IN THE TREATMENT OF INFLAMMATORY DISEASE
#171Pathogen for bacterial poultry disease
#172Vaccination for
#173TOXIN-ANTITOXIN SYSTEM AND APPLICATIONS THEREOF
#174Coccidiosis vaccines
#175Oral vaccines
#176Method of producing rough strains of bacteria and uses thereof
#177Yeast-antigen compositions and methods of using the same
#178Use of Whole Bacterial Cells (Actinomycetales) for Maternal Administration to Modulate Offspring Immune Response
#179system and uses thereof
#180Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
#181Pathogen for bacterial poultry disease
#182Use of Whole Cell Actinomycetales Bacteria to Treat Stress-Induced Pulmonary Haemorrhage
#183Vaccine Composition
#184Pseudomonas Aeruginosa Outer Membrane Protein PA5158
#185Induction of mucosal tolerance to antigens
#186Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis
#187VACCINE FOR NONTYPEABLE HAEMOPHILUS INFLUENZAE INFECTION
#188Methods for Treatment and Prevention of Infection
#189BIFIDOBACTERIUM IN THE TREATMENT OF INFLAMMATORY DISEASE
#190Soft gel delivery system for treating poultry
#191Intact Minicells as Vectors for DNA Transfer and Gene Therapy In Vitro and In Vivo
#192Use of cross-protection to identify novel vaccine candidates for infectious agents
#193Use of cross-protection to identify novel vaccine candidates for infectious agents
#194FORMULATIONS USEFUL FOR IMMUNOTHERAPY FOR CANCERS CONTAINING BACTERIAL COMPONENT AS AN ACTIVE INGREDIENT
#195Vaccination method for controlling coccidiosis in fowl
#196Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
#197Use of cross-protection to identify novel vaccine candidates for infectious agents
#198Bifidobacterium in the treatment of inflammatory disease
#199Coccidiosis vaccines
#200INTACT MINICELLS AS VECTORS FOR DNA TRANSFER AND GENE THERAPY INVITRO AND INVIVO
#201Vaccine composition against
#202Trehalose producing cells as vaccines
#203Methods for the in vitro culture of sp. and uses thereof
#204Yeast-antigen compositions methods of making the same
#205Bifidobacterium in the treatment of inflammatory disease
#206Use of lactobacillus salivarius
#207Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
#208Virulence genes and proteins from Brucella melitensis, and their use
#209Vaccine composition
#210Lactic acid bacteria capable of stimulating mucosal immunity
#211Vaccine composition
#212Methods for producing oocysts
#213Yeast-dendritic cell vaccines and uses thereof
#214Composition for delivering an agent to a target cell and uses thereof
#215Acellular antibordetella vaccine
#216Immunization with porphyromonas gingivalis protects against heart disease
#217Helicobacter system and uses thereof
#218Bifidobacterium in the treatment of inflammatory disease
#219Vaccine for nontypeable infection
#220Live antenuated parasite vaccine
#221Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
#222Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
#223Bifidobacterium in the treatment of inflammatory disease
#224Probiotic propionibacterium
#225Use of lactobacillus salivarius
#226antigens and their vaccine and diagnostic applications
#227Bifidobacterium in the treatment of inflammatory disease
#228Composition for delivering an agent to a target cell and uses thereof
#229Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#230Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#231Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#232Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#233Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#234Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#235Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
#236Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity